Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Kinross Gold Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Kinross Gold Corporation trades at $22.71 (market cap $26.40B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Kinross Gold Corporation pays the higher dividend (0.72%). Which is the better fit depends on your goals.
| GEHC | KGC | |
|---|---|---|
Market Cap | $30.93B | $26.40B |
Volume | 5,033,451 | 10,366,257 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $38.06 |
52-Week Low | $59.48 | $22.24 |
Enterprise Value | $39.39B | $24.48B |
Dividend Yield | 0.23% | 0.72% |
Typical Hold Time | — | 53 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Kinross Gold (KGC) trades at $23.44, down 0.47% on the day, amid a bearish technical signal despite strong fundamental performance. The company reported robust earnings beats in recent quarters with Q2 2026 EPS of $0.71 exceeding expectations, while revenue grew to $7.05 billion in 2025. However, recent news highlights production guidance cuts for 2026-2027 and ongoing legal investigations, creating mixed sentiment. Technical indicators show the stock trading near key support at $23 with RSI levels suggesting potential oversold conditions.
KGC presents a compelling value opportunity with attractive valuation multiples (P/E 8.91, EV/EBITDA 4.6) and strong profitability margins (net income margin 37.52%). The company's increasing cash flow generation and shareholder return framework support upside potential toward the $38.80 consensus price target. Key risks include production challenges at key mines, rising operating costs, and legal uncertainties that could pressure near-term performance despite the positive long-term gold price environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
